BFRI News and Press, Biofrontera Inc.

2026-06-11 11:42:13 ET Biofrontera Inc. (BFRI) Shareholder/Analyst Call June 11, 2026 10:00 AM EDT Company Participants Hermann Lubbert - CEO, President & Chairman Presentation Operator ... Hello, and welcome to the Annual Meeting of Stock...

2026-06-02 13:16:02 ET Image source: The Motley Fool. Thursday, March 19, 2026 at 10 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

WOBURN, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), will participate in a webcast presentation...

2026-05-14 15:40:56 ET More on Biofrontera Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin Biofrontera outl...

2026-05-14 13:31:45 ET More on Biofrontera Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition Seekin...

2026-05-14 13:30:55 ET Biofrontera Inc. (BFRI) Q1 2026 Earnings Call May 14, 2026 11:00 AM EDT Company Participants Hermann Lubbert - CEO, President & Chairman George Jones - Chief Commercial Officer Eugene Leffler - Chief Financial Officer ... Read t...

Woburn, MA, May 14, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology, today reported financial results for the three months ended March 31, 2026 ...

The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protectio...

WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), announces it will report financial result...

2026-03-19 15:18:24 ET More on Biofrontera Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript Biofrontera sees Q4 2025 net sales of about $17M to $17.5M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera ...